Rigel Pharmaceuticals RIGL
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: +$5.11M (13 inflow days, 7 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 43.0% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 17.15% to 13.57% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Morgan Stanley | Public Company | 2026/Q3 | +1,070,770 | 6.7% |
| Morgan Stanley Investment Management Inc. | Mutual Fund | 2026/Q3 | +1,070,770 | 6.7% |
| Assenagon Asset Management S.A. | Mutual Fund | 2026/Q3 | +535,685 | 2.8% |
| American Century Investment Management | Mutual Fund | 2026/Q3 | +302,248 | 5.5% |
| BlackRock | Mutual Fund | 2026/Q3 | +125,958 | 11.0% |
| LSV Asset Management | Mutual Fund | 2026/Q3 | +65,742 | 4.2% |
| UBS Asset Management | Mutual Fund | 2026/Q3 | +52,673 | 0.9% |
| Sterling Capital Management LLC | Mutual Fund | 2026/Q3 | +45,329 | 0.2% |
| Knights of Columbus Asset Advisors LLC | Mutual Fund | 2026/Q3 | +30,435 | 0.2% |
| Martingale Asset Management, L.P. | Mutual Fund | 2026/Q3 | +22,066 | 0.1% |
| Soleus Capital Management, L.P. | Hedge Fund | 2026/Q3 | +1,833,504 | 9.8% |
| Armistice Capital LLC | Hedge Fund | 2026/Q3 | +392,000 | 8.9% |
| American Century Investment Management | Mutual Fund | 2026/Q3 | +197,287 | 4.0% |
| Macquarie Investment Management Business Trust | Mutual Fund | 2026/Q3 | +195,000 | 1.0% |
| Bridgeway Capital Management, LLC | Mutual Fund | 2026/Q3 | +190,848 | 1.1% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 1 Sep 2026 | Dean Schorno | Chief Financial Officer | Derivative Exercise and Retained | +4,600 | $24.20 | 44,079 |
| 31 Aug 2026 | Raul Rodriguez | Chief Executive Officer | Sale to Issuer | -2,424 | $47.50 | 179,400 |
| 31 Aug 2026 | Dean Schorno | Chief Financial Officer | Sale to Issuer | -928 | $47.50 | 44,079 |
| 31 Aug 2026 | Raymond Furey | Executive VP, Chief Compliance Officer, General Counsel & Corporate Secretary | Sale to Issuer | -877 | $47.50 | 14,201 |
| 31 Aug 2026 | David Santos | Executive Vice President | Sale to Issuer | -874 | $47.50 | 23,320 |
| 7 Jul 2026 | Alison Hannah | Chief Medical Officer | Other Acquisition | +24,400 | – | 24,400 |
| 21 Jun 2026 | Kamil Jackson | Independent Director | Automatic Disposition | -2,500 | $35.00 | 10,125 |
| 16 Jun 2026 | Raul Rodriguez | Chief Executive Officer | Other Derivative Acquisition | +31,700 | $22.49 | 31,700 |
| 16 Jun 2026 | Lisa Rojkjaer | Former Chief Medical Officer | Other Derivative Acquisition | +16,769 | $22.49 | 7,394 |
| 16 Jun 2026 | Dean Schorno | Chief Financial Officer | Other Derivative Acquisition | +7,394 | $22.49 | 7,394 |
| 16 Jun 2026 | Raymond Furey | Executive VP, Chief Compliance Officer, General Counsel & Corporate Secretary | Other Derivative Acquisition | +7,394 | $22.49 | 7,394 |
| 16 Jun 2026 | David Santos | Executive Vice President | Other Derivative Acquisition | +7,394 | $22.49 | 7,394 |
| 31 May 2026 | Raul Rodriguez | Chief Executive Officer | Sale to Issuer | -2,424 | $29.86 | 181,138 |
| 31 May 2026 | Lisa Rojkjaer | Former Chief Medical Officer | Sale to Issuer | -850 | $29.86 | 3,539 |
| 31 May 2026 | Dean Schorno | Chief Financial Officer | Derivative Exercise and Sale | -928 | $29.86 | 38,187 |
| 31 May 2026 | Dean Schorno | Chief Financial Officer | Derivative Exercise and Retained | +2,453 | $18.70 | 38,187 |
| 31 May 2026 | Raymond Furey | Executive VP, Chief Compliance Officer, General Counsel & Corporate Secretary | Sale to Issuer | -877 | $29.86 | 12,952 |
| 31 May 2026 | David Santos | Executive Vice President | Sale to Issuer | -874 | $29.86 | 22,074 |
| 25 May 2026 | Kamil Jackson | Independent Director | Automatic Disposition | -2,500 | $29.17 | 6,875 |
| 14 May 2026 | Walter Moos | Independent Director | Other Acquisition | +5,750 | – | 5,750 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 2,535,665 | 13.6% | 12.9 |
| 15 Oct 2026 | 2,732,739 | 14.6% | 12.8 |
| 30 Sep 2026 | 2,855,433 | 15.3% | 11.1 |
| 15 Sep 2026 | 3,191,811 | 17.1% | 15.8 |
| 31 Aug 2026 | 3,182,110 | 17.0% | 9.1 |
| 14 Aug 2026 | 3,203,364 | 17.1% | 9.8 |
No comments yet — be the first to weigh in on RIGL.
Sign in to join the discussion.